Using migraine medicines to treat Meniere’s disease symptoms
Part of Brain & nervous system, Ear, nose & throat clinical trials.
This Phase 4 study tests whether migraine-type medications can help people with active or frequent Meniere’s disease. If you have symptoms like inner-ear episodes, the trial may help find a better way to control them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have active or frequent Meniere’s disease symptoms
- You are between 25 and 85 years old
- You can reliably take the study medication and come to study visits
- You can read and write in English for consent and study forms
- If you can get pregnant, you must pass a pregnancy test (pregnancy means you cannot join)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a mild electrical current applied behind the ear can reduce dizziness and hearing problems in people with Meniere's disease. It may help those who still get vertigo attacks despite taking standard medications.
This study tests whether migraine prevention medications, including newer anti-CGRP drugs, can reduce ringing in the ears (tinnitus) in people who have migraine or related headache disorders. If you have had tinnitus for at least 6 months and have a history of migraine, you may be able to join.
This Phase 3 study compares injections of steroid medicine into the ear versus a dummy (placebo) injection to see if it reduces vertigo attacks in people with Ménière’s disease. It may help by improving balance symptoms and reducing how often attacks happen.
This trial tests an oral solution of isosorbide, a medication that may reduce fluid buildup in the inner ear, to see if it can prevent vertigo attacks in people with Meniere's disease. It could be an option if you have frequent, one-sided vertigo and have not had prior ear surgeries or certain injections.
This trial compares two first-line migraine prevention medications in primary care. It's designed for adults who have frequent migraines (4 to 14 days per month) and have not yet tried a preventive medication.
This trial tests if a gentle nasal stimulation device can help prevent migraines. It is for adults with frequent migraines (at least 8 days per month).
Hear when a new Ménière trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.